News
Jumpcode Genomics Secures $21M in Series B Funding
Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub SAN DIEGO, CA – Jumpcode Genomics – a genome technology company focused on improving the understanding […]
Q&A: A Jump to the Next Step in Sequencing
Jumpcode details how its CRISPRclean tech unites NGS and CRISPR/Cas editing Kelsey Kaustinen details how Jumpcode’s CRISPRclean technology unites NGS and CRISPR/Cas editing in a Q&A with our Chief Scientist, Dr. Stanley Nelson, in the current issue of Drug Discovery News. Read on to hear Dr. Nelson’s perspective on how CRISPRclean can benefit life sciences […]
Jumpcode Genomics Exits Stealth Mode, Unveils Technology That Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology
Patented CRISPRclean® Technology is a Foundational Tool that Improves the Performance of Next-Generation Sequencing and Other Molecular Workflows by Increasing Sensitivity, Reducing Costs and Enabling Novel Discovery CARLSBAD, Calif. – Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced […]